Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 5 Thromboembolism 4 Neoplasms 4 Venous Thrombosis 3 Pancreatic Neoplasms 3 Pulmonary Embolism 2 Ovarian Neoplasms 2 Venous Thormboembolism 1 Thrombosis 1 Stroke 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Abdominal Neoplasms 1

Interventions

Nutrition Assessment 3 rimabotulinumtoxinB 1 Resistance Training 1 Massage 1 Lysine Acetyltransferase 5 1 Hematologic Tests 1 Extracorporeal Shockwave Therapy 1 Enoxaparin 1 Cholecalciferol 1 Botulinum Toxins, Type A 1 Aspirin 1 Animal Assisted Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Stroke × Enoxaparin × Clear all

NCT01763606 2020-08-14

Enoxaparin Versus Aspirin in Patients With Cancer and Stroke

Memorial Sloan Kettering Cancer Center

Phase NA Completed

20 enrolled 11 charts

Stroke

Data powered by HemOnc (CC BY 4.0) Colophon ⚡